Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Published Online
on February 15, 2007

Arteriosclerosis, Thrombosis, and Vascular Biology. 2007
Published online before print February 15, 2007, doi: 10.1161/ATVBAHA.106.138594
A more recent version of this article appeared on May 1, 2007
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
27/5/1166    most recent
ATVBAHA.106.138594v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by López-Bermejo, A.
Right arrow Articles by Fernández-Real, J.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by López-Bermejo, A.
Right arrow Articles by Fernández-Real, J.-M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CHOLESTEROL
Medline Plus Health Information
*Vascular Diseases

Submitted on December 19, 2006
Accepted on February 1, 2007

Alpha Defensins 1, 2, and 3. Potential Roles in Dyslipidemia and Vascular Dysfunction in Humans

Abel López-Bermejo *; Berta Chico-Julià ; Antoni Castro ; Mònica Recasens ; Eduardo Esteve ; Josefina Biarnés ; Roser Casamitjana ; Wifredo Ricart ; and José-Manuel Fernández-Real

From the Diabetes, Endocrinology, and Nutrition Unit (A.L.-B., B.C.-J., M.R., E.E., J.B., W.R., J.-M.F.-R.) and Internal Medicine (A.C.), Dr Josep Trueta Hospital, Girona; the Girona Institute for Biomedical Research (A.L.-B., B.C.-J., A.C., M.R., E.E., J.B., W.R., J.-M.F.-R.), Girona; and the Endocrine Laboratory (R.C.), University Clinical Hospital, Barcelona, Spain.

* To whom correspondence should be addressed. E-mail: uden.alopez{at}htrueta.scs.es.

Objectives--{alpha}-Defensins are natural antibiotics made by neutrophils that have been reported to modulate cholesterol metabolism and vascular function; however, their role in vivo remains largely unknown. We hypothesized that {alpha}-defensins 1 to 3 (DEFA1-3) are associated with serum lipids and vascular reactivity in humans.

Methods and results--One hundred thirteen apparently-healthy White men, participants in a prospective study of cardiovascular risk factors, were assessed for a lipid profile, insulin sensitivity (SI, frequently-sampled intravenous glucose tolerance test), and non-stressed circulating DEFA1-3 (ELISA). In a subset of 52 subjects, vascular reactivity (high-resolution ultrasound of the brachial artery) was also assessed. Subjects in the highest quartile for plasma DEFA1-3 were found to be leaner and more insulin sensitive, and to have significantly reduced total and LDL-cholesterol, compared with subjects in the lowest quartile for circulating DEFA1-3 (P<0.0001 to P=0.002 for linear trend ANOVA). The associations with serum lipids persisted after adjustment for age, body mass index, insulin sensitivity, and smoking (which was associated with reduced plasma DEFA1-3 concentrations). Finally, endothelium-independent vasodilation increased with increasing circulating DEFA1-3 (P=0.003) and this association was not explained by age, body mass index, serum cholesterol, insulin sensitivity, or smoking.

Conclusions--Circulating DEFA1-3 are associated with serum cholesterol and vascular reactivity in humans. {alpha}-Defensins may have clinical implications in patients with either hypercholesterolemia or vascular dysfunction.


Key words: human neutrophil peptide • defensin • cholesterol • insulin resistance • vascular function.




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Quinn, M. Henriques, T. Parker, A. S. Slutsky, and H. Zhang
Human neutrophil peptides: a novel potential mediator of inflammatory cardiovascular diseases
Am J Physiol Heart Circ Physiol, November 1, 2008; 295(5): H1817 - H1824.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
F. Syeda, E. Tullis, A. S. Slutsky, and H. Zhang
Human neutrophil peptides upregulate expression of COX-2 and endothelin-1 by inducing oxidative stress
Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2769 - H2774.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
J. M. Moreno-Navarrete, F. J. Ortega, J. Bassols, A. Castro, W. Ricart, and J. M. Fernandez-Real
Association of Circulating Lactoferrin Concentration and 2 Nonsynonymous LTF Gene Polymorphisms with Dyslipidemia in Men Depends on Glucose-Tolerance Status
Clin. Chem., February 1, 2008; 54(2): 301 - 309.
[Abstract] [Full Text] [PDF]